Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Mutations in the TSC1 or TSC2 tumor suppressor genes lead to tuberous sclerosis complex (TSC), a dominant hamartomatous disorder that often presents with mental retardation, epilepsy and autism. The etiology of these neurological symptoms is unclear and the function of the TSC pathway in neurons is unknown. We found that in post-mitotic, hippocampal pyramidal neurons of mice and rats, loss of Tsc1 or Tsc2 triggered enlargement of somas and dendritic spines and altered the properties of glutamatergic synapses. Furthermore, loss of a single copy of the Tsc1 gene was sufficient to perturb dendritic spine structure. Morphological changes required regulation of the actin-depolymerization factor cofilin at a conserved LIM-kinase phosphorylation site, the phosphorylation of which was increased by loss of Tsc2. Thus, the TSC pathway regulates growth and synapse function in neurons, and perturbations of neuronal structure and function are likely to contribute to the pathogenesis of the neurological symptoms of TSC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immunostaining of hippocampi from these mice showed an increase in the downstream marker of mTORC1 activity, phospho-S6 ribosomal protein, along with the typical increase in cell body size relative to control (Fig. 8C and supplemental Fig. S6) (84).”
In the citing paper
“Second, *Tsc1*−/− hippocampal neurons were shown to have morphological and functional synaptic abnormalities[26](#R26).”
From Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis (2008) · cites this paper as [26]
In the citing paper
“and TSC1 or TSC2 loss causes enlarged spines39.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [39]
In the citing paper
“Individuals with mutations of tuberous sclerosis proteins 1 and 2 (TSC1, TSC2) or the phosphatase and tensin homolog (PTEN) gene, which causes macroencephaly, are frequently diagnosed with autism38 and each of these proteins regulates synaptic structure39,40.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [39]
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181 · cited 1×
“and upregulates mTOR, which, through multiple actions, enhances protein translation and cell growt”
BackgroundA simple method for organotypic cultures of nervous tissue
Stoppini, L., Buchs, P.-A., & Muller, D. (1991) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(91)90128-m · Cited by 3,089 · cited 1×
“Organotypic slice cultures were prepared from P5–P7 mice and rat”
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083 · cited 1×
“In vitro , Akt phosphorylates TSC2 at conserved consensus phosphorylation sequences and downregulates its GTPase-activating protein (GAP) activit”
BackgroundSarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex
Trachtenberg, J. T., Chen, B. E., Knott, G. W., Feng, G., Sanes, J. R., Welker, E., & Svoboda, K. (2002) · Nature · doi:10.1038/nature01273 · Cited by 1,927
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555 · cited 1×
“In vitro , Akt phosphorylates TSC2 at conserved consensus phosphorylation sequences and downregulates its GTPase-activating protein (GAP) activit”
BackgroundRegulation of actin dynamics through phosphorylation of cofilin by LIM-kinase
Arber, S., Barbayannis, F. A., Hanser, H., Schneider, C., Stanyon, C. A., Bernard, O., & Caroni, P. (1998) · Nature · doi:10.1038/31729 · Cited by 1,425
Insulin Activation of Rheb, a Mediator of mTOR/S6K/4E-BP Signaling, Is Inhibited by TSC1 and 2
Garami, A., Zwartkruis, F. J. T., Nobukuni, T., Joaquin, M., Roccio, M., Stocker, H., Kozma, S. C., Hafen, E., Bos, J. L., & Thomas, G. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00220-x · Cited by 1,043 · cited 1×
“Reduced GAP activity allows the buildup of GTP-bound Rhe”
BackgroundShrinkage of dendritic spines associated with long-term depression of hippocampal synapses
Zhou, Q., Homma, K. J., & Poo, M.-M. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.011 · Cited by 1,025
Cited by
Items 101–200 of 495
Ehninger, D., De Vries, P. J., & Silva, A. J. (2009) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2009.01208.x · Cited by 120
“As discussed below, TSC-mTOR signalling plays several important roles in the mature nervous system, such as the regulation of synaptic functions, including plasticity (Tang et al. 2002; Kelleher et al. 2004; Sutton & Schuman 2005; Tavazoie et al. 2005; Ehninger et al. 2008a), but also controls glia-mediated functions…”
BackgroundSundberg, M., Tochitsky, I., Buchholz, D. E., Winden, K. D., Kujala, V. J., Kapur, K., Cataltepe, D., Turner, D., Han, M., Woolf, C. J., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0018-4 · Cited by 127
“Here we detected mTORC1 pathway overactivation and significantly enlarged cell size and number of neurites in TSC2+/− and TSC2 PCs compared with control cells after long-term culture in vitro, which is consistent with the presence of enlarged dysplastic neuronal cells and giant cells in human tubers [60, 61] and enlar…”
ResultCosta, V., Aigner, S., Vukcevic, M., Sauter, E., Behr, K., Ebeling, M., Dunkley, T., Friedlein, A., Zoffmann, S., Meyer, C. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.090 · Cited by 119
“Deletion of TSC1/2 in animal models affects a wide range of neuronal processes, and inhibition of mTORC1 corrects specific cellular, neuroanatomical, and neurological phenotypes (Meikle et al., 2007, 2008; Magri et al., 2011; Bateup et al., 2013; Tavazoie et al., 2005).”
BackgroundRetraction of Synapses and Dendritic Spines Induced by Off-Target Effects of RNA Interference
Alvarez, V. A., Ridenour, D. A., & Sabatini, B. L. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1957-06.2006 · Cited by 120
“were performed as described previously (Tavazoie et al., 2005) using a”
MethodInfluentialSelf-citationRusso, E., Citraro, R., Donato, G., Camastra, C., Iuliano, R., Cuzzocrea, S., Constanti, A., & Sarro, G. D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.09.019 · Cited by 122
“…et al., 2006) and ligand-gated ion channels (Sabatini et al., 1999; Wang et al., 2006) and transporters (Li et al., 2006), as well as inhibiting dendritic growth (Jaworski et al., 2005; Kumar et al., 2005; Huang et al., 2007) and changing dendritic spine morphology (Tavazoie et al., 2005).”
Malformations of Cortical Development
Aronica, E., Becker, A. J., & Spreafico, R. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00581.x · Cited by 114
“Abnormal glutamate homeostasis, increased AMPAreceptor-mediated currents, impaired astrocytic gap junction coupling and potassium buffering, which would support seizure generation, have been described in mouse models of TSC (203, 216, 223, 228).”
BackgroundmTOR, a Potential Target to Treat Autism Spectrum Disorder
Sato, A. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160413120638 · Cited by 113
“Altered structure, an increased number of dendritic spines, and impaired axon guidance are also associated with TSC [57, 58].”
BackgroundSTRADα deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice
Orlova, K. A., Parker, W. E., Heuer, G. G., Tsai, V., Yoon, J., Baybis, M., Fenning, R. S., Strauss, K., & Crino, P. B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41592 · Cited by 111
Mukhtar, I. (2020) · Seizure · doi:10.1016/j.seizure.2020.09.015 · Cited by 130
Bialer, M., Johannessen, S. I., Levy, R. H., Perucca, E., Tomson, T., & White, H. S. (2017) · Epilepsia · doi:10.1111/epi.13634 · Cited by 124
Genetic control of postnatal human brain growth
van Dyck, L. I., & Morrow, E. M. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000405 · Cited by 118
Drug discovery for autism spectrum disorder: challenges and opportunities
Ghosh, A., Michalon, A., Lindemann, L., Fontoura, P., & Santarelli, L. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4102 · Cited by 108
Ruppe, V., Dilsiz, P., Reiss, C. S., Carlson, C., Devinsky, O., Zagzag, D., Weiner, H. L., & Talos, D. M. (2014) · Epilepsia · doi:10.1111/epi.12545 · Cited by 109
ADF/cofilin: a crucial regulator of synapse physiology and behavior
Rust, M. B. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1941-z · Cited by 119
“Loss of either TSC1 or TSC2 resulted in enlarged spines, and functional data revealed that these morphological changes require ADF/cofilin inactivation [58].”
Han, J., Wang, B., Xiao, Z., Gao, Y., Zhao, Y., Zhang, J., Chen, B., Wang, X., & Dai, J. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.06.003 · Cited by 120
“Recent studies reveal a more extensive involvement of mTOR in neuronal developmental processes such as axon guidance, dendrite development, and dendritic spine morphogenesis (Campbell and Holt, 2001; Jaworski et al., 2005; Kumar et al., 2005; Tavazoie et al., 2005).”
Buckley, A. W., & Holmes, G. L. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022749 · Cited by 106
“Functional mutations in Tsc1 or Tsc2 significantly alter synapse structure, function, and plasticity (Tavazoie et al. 2005; Ehninger et al. 2008; Auerbach et al. 2011; Bateup et al. 2011; Chevere-Torres et al. 2012).”
TSC1/TSC2 signaling in the CNS
Han, J. M., & Sahin, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.02.001 · Cited by 105
“Interestingly, Tsc1 or Tsc2 loss increased spine length and head width and decreased the density of dendritic spines in hippocampal slice cultures [68].”
BackgroundDendritic spine pathology in epilepsy: Cause or consequence?
Wong, M., & Guo, D. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.048 · Cited by 118
“Furthermore, the dendritic spine abnormalities induced by TSC2 loss are at least partially reversed by the drug rapamycin, which inhibits the mammalian target of rapamycin (mTOR), a central regulatory kinase primarily controlling protein translation.”
InfluentialNeuronal Autophagy and Neurodevelopmental Disorders
Lee, K.-M., Hwang, S.-K., & Lee, J.-A. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.3.133 · Cited by 103
“Signal transduction via mTOR is known to be required for synaptic plasticity [46], and enhancement of mTOR activity in tuberous sclerosis is involved not only in the impairment of hippocampal mGluR-LTD (long-term depression) [47, 48], but also dendritic spine plasticity, which alters the characteristics of glutamaterg…”
BackgroundLoss of CLOCK Results in Dysfunction of Brain Circuits Underlying Focal Epilepsy
Li, P., Fu, X., Smith, N., Ziobro, J. M., Curiel, J., Tenga, M. J., Martin, B. S., Freedman, S., Rio, C. A. C.-D., Oboti, L., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.044 · Cited by 103
Deregulated mTOR-mediated translation in intellectual disability
Troca-Marín, J. A., Alves-Sampaio, A., & Montesinos, M. L. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.01.005 · Cited by 118
Mühlebner, A., Bongaarts, A., Sarnat, H. B., Scholl, T., & Aronica, E. (2019) · Journal of Anatomy · doi:10.1111/joa.12956 · Cited by 99
“The mechanistic link between genetic mutations, dysregulation of mTOR pathway and excitatory/ inhibitory synaptic imbalance leading to hyperexcitability has also been supported by different experimental studies (Tavazoie et al. 2005; Bateup et al. 2013; Lozovaya et al. 2014; Santos et al. 2017).”
ResultThe tuberous sclerosis complex proteins – a GRIPP on cognition and neurodevelopment
de Vries, P. J., & Howe, C. J. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.06.003 · Cited by 84
Cellular and synaptic network defects in autism
Peça, J., & Feng, G. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.02.015 · Cited by 96
mTOR Inhibition in Epilepsy: Rationale and Clinical Perspectives
Ostendorf, A. P., & Wong, M. (2015) · CNS Drugs · doi:10.1007/s40263-014-0223-x · Cited by 103
Cichon, J., Sun, C., Chen, B., Jiang, M., Chen, X. A., Sun, Y., Wang, Y., & Chen, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.301911 · Cited by 95
Epilepsy Related to Developmental Tumors and Malformations of Cortical Development
Aronica, E., & Crino, P. B. (2014) · Neurotherapeutics · doi:10.1007/s13311-013-0251-0 · Cited by 106
“Mouse models of TSC point to additional mechanisms that would support seizure generation, such as abnormal glutamate homeostasis, increased αamino-3-hydroxy-5-methyl-4-isixazolepropionic acidreceptor-mediated currents, impaired astrocytic gap junction coupling, and potassium buffering [221, 225, 226].”
BackgroundNeural Mechanisms Underlying Repetitive Behaviors in Rodent Models of Autism Spectrum Disorders
Gandhi, T., & Lee, C. C. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592710 · Cited by 88
Feliciano, D. M., Lin, T. V., Hartman, N. W., Bartley, C. M., Kubera, C., Hsieh, L. S., Lafourcade, C., O’Keefe, R. A., & Bordey, A. (2013) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2013.02.008 · Cited by 95
Way, S. W., Rozas, N. S., Wu, H. C., McKenna, J., Reith, R. M., Hashmi, S. S., Dash, P. K., & Gambello, M. J. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds156 · Cited by 92
A Subset of Autism-Associated Genes Regulate the Structural Stability of Neurons
Lin, Y., Frei, J. A., Kilander, M. B. C., Shen, W., & Blatt, G. J. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00263 · Cited by 110
“TSC1/2 regulates the mTOR pathway and cytoskeletal machinery to maintain dendritic stability.”
BackgroundInfluentialDynamic Akt/mTOR Signaling in Children with Autism Spectrum Disorder
Onore, C. E., Yang, H. T., de Water, J. V., & Ashwood, P. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00043 · Cited by 103
Perfect match: mTOR inhibitors and tuberous sclerosis complex
Luo, C., Ye, W.-R., Shi, W., Yin, P., Chen, C., He, Y., Chen, M., Zu, X., & Cai, Y. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02266-0 · Cited by 115
Metformin for treatment of fragile X syndrome and other neurological disorders
Gantois, I., Popic, J., Khoutorsky, A., & Sonenberg, N. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-081117-041238 · Cited by 87
Roles for neuronal and glial autophagy in synaptic pruning during development
Lieberman, O. J., McGuirt, A. F., Tang, G., & Sulzer, D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.04.017 · Cited by 87
“They however reported increased spine length, decreased spine density and disruption in soma size in primary neuronal culture (Tavazoie et al., 2005).”
BackgroundNon‐canonical functions of the tuberous sclerosis complex‐Rheb signalling axis
Neuman, N. A., & Henske, E. P. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100131 · Cited by 86
“Surprisingly, both knockdown of Tsc2 in cultured rat neurons and Rapamycin treatment of WT neurons resulted in enhanced EMBO Mol Med 3, 189–200 www.embomolmed.org dendritic spine length (Tavazoie et al, 2005).”
BackgroundmTOR dysregulation and tuberous sclerosis-related epilepsy
Curatolo, P., Moavero, R., van Scheppingen, J., & Aronica, E. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1428562 · Cited by 85
Tsai, P., & Sahin, M. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32834451c4 · Cited by 84
Dendritic pathology, spine loss and synaptic reorganization in human cortex from epilepsy patients
Rossini, L., Santis, D. D., Mauceri, R., Tesoriero, C., Bentivoglio, M., Maderna, E., Maiorana, A., Deleo, F., de Curtis, M., Tringali, G., et al. (2020) · Brain · doi:10.1093/brain/awaa387 · Cited by 86
Copf, T. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.008 · Cited by 98
“Of note to the discussion in this review is the fact that TSC1 and TSC2 genes have been reported to play important roles both in dendritic spine morphology [298] and in large-scale neurite growth and”
George, C., Gontier, G., Lacube, P., François, J.-C., Holzenberger, M., & Aïd, S. (2017) · Brain · doi:10.1093/brain/awx132 · Cited by 84
“…reduction in soma size, specifically of apical cytoplasm and primary dendrite in response to IGF1R deletion (Gontier et al., 2015), or after interfering with downstream PI3k-Akt-mTOR signalling in mice (Tavazoie et al., 2005; Cloetta et al., 2013; Thomanetz et al., 2013; Goebbels et al., 2017).”
BackgroundChévere-Torres, I., Kaphzan, H., Bhattacharya, A., Kang, A., Maki, J. M., Gambello, M. J., Arbiser, J. L., Santini, E., & Klann, E. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.028 · Cited by 83
Everolimus in tuberous sclerosis patients with intractable epilepsy: A treatment option?
Wiegand, G., May, T. W., Ostertag, P., Boor, R., Stephani, U., & Franz, D. N. (2013) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2013.06.002 · Cited by 82
Han, S., Witt, R. M., Santos, T. M., Polizzano, C., Sabatini, B. L., & Ramesh, V. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.01.020 · Cited by 90
Self-citationWolf, M., Zimmermann, A.-M., Görlich, A., Gurniak, C. B., Sassoè-Pognetto, M., Friauf, E., Witke, W., & Rust, M. B. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhu081 · Cited by 80
“…the relevance of ADF/cofilin for spine morphology (Zhou et al. 2004; Hotulainen et al. 2009; Gu et al. 2010), and a number of upstream regulatory mechanisms have been identified (Tavazoie et al. 2005; Schratt et al. 2006; Zhou et al. 2007; Shi et al. 2009; McNair et al. 2010; Zhou et al. 2012).”
BackgroundEverolimus: an mTOR inhibitor for the treatment of tuberous sclerosis
Franz, D. N. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.11.93 · Cited by 78
Rheb and mTOR Regulate Neuronal Polarity through Rap1B
Li, Y.-H., Werner, H., & Püschel, A. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802431200 · Cited by 78
Is the mTOR‐signalling cascade disrupted in Schizophrenia?
Gururajan, A., & van den Buuse, M. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12622 · Cited by 78
Focal cortical dysplasia: a review of pathological features, genetics, and surgical outcome
Wang, V. Y., Chang, E. F., & Barbaro, N. M. (2006) · Neurosurgical FOCUS · doi:10.3171/foc.2006.20.1.8 · Cited by 77
Sliwa, A., Plucińska, G., Bednarczyk, J., & Łukasiuk, K. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.12.051 · Cited by 77
Reijnders, M. R. F., Kousi, M., van Woerden, G. M., Klein, M., Bralten, J., Mancini, G. M. S., van Essen, T., Proietti-Onori, M., Smeets, E. E. J., van Gastel, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00933-6 · Cited by 76
Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis
McDaniel, S. S., & Wong, M. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.02.037 · Cited by 85
“In neuronal development, mTOR is critical for axon guidance in response to extracellular cues, and in dendrite development and dendritic spine morphogenesis [14, 51, 58, 80, 101, 103].”
BackgroundBell, J. J. L., Rakhade, S. N., Klein, P., Obeid, M., Jackson, M. C., Joseph, A., & Jensen, F. E. (2013) · Epilepsia · doi:10.1111/epi.12378 · Cited by 81
“Because we have previously implicated seizure-induced activation of AMPARs and the mTOR pathway, we hypothesized that increased AMPAR activity drives several downstream consequences of neonatal HS (Sarbassov et al., 2005; Tavazoie et al., 2005; Sengupta et al., 2010; Bateup et al., 2011).”
BackgroundMonogenic mouse models of autism spectrum disorders: Common mechanisms and missing links
Hulbert, S. W., & Jiang, Y. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.040 · Cited by 86
“Organotypically cultured hippocampal neurons lacking Tsc1 have higher amplitudes in mEPSCs and increased AMPA/NMDA current ratios (Tavazoie et al., 2005).”
BackgroundTsc1-mTORC1 signaling controls striatal dopamine release and cognitive flexibility
Kosillo, P., Doig, N. M., Ahmed, K. M., Agopyan-Miu, A. H. C. W., Wong, C. D., Conyers, L., Threlfell, S., Magill, P. J., & Bateup, H. S. (2019) · Nature Communications · doi:10.1038/s41467-019-13396-8 · Cited by 77
mTOR signalling pathway - A root cause for idiopathic autism?
Ganesan, H., Balasubramanian, V., Iyer, M., Venugopal, A., Subramaniam, M. D., Cho, S.-G., & Vellingiri, B. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.7.137 · Cited by 73
Koeglsperger, T., Li, S., Brenneis, C., Saulnier, J. L., Mayo, L., Carrier, Y., Selkoe, D. J., & Weiner, H. L. (2013) · Glia · doi:10.1002/glia.22490 · Cited by 73
“described (Shankar et al., 2007; Tavazoie et al., 2005).”
MethodThe PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia
Enríquez-Barreto, L., & Morales, M. (2016) · Journal of Green Engineering · doi:10.1186/s40591-016-0047-9 · Cited by 79
“Similar to PTEN mutations, inhibitory mutations in any of the TSC elements of the complex would result in an imbalance in mTORC1 activity, increasing protein translation and modifying neuronal morphology [30, 70].”
BackgroundConvergent and Divergent Mechanisms of Epileptogenesis in mTORopathies
Nguyen, L. H., & Bordey, A. (2021) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2021.664695 · Cited by 71
“…in in vitro (primarily in hippocampal neurons and some in cortical neurons) and transgenic mouse models of mTORopathies [for some examples, see: (Tavazoie et al., 2005; Wang et al., 2007; Bateup et al., 2011, 2013; Luikart et al., 2011; Weston et al., 2012; Xiong et al., 2012; De Fusco et al.,…”
BackgroundCortical wiring by synapse type–specific control of local protein synthesis
Bernard, C., Exposito-Alonso, D., Selten, M., Sanalidou, S., Hanusz-Godoy, A., Aguilera, A., Hamid, F., Oozeer, F., Maeso, P., Allison, L., et al. (2022) · Science · doi:10.1126/science.abm7466 · Cited by 81
“S1, C and E), reinforcing the notion that mTOR signaling is indeed overactive in these cells (27, 28).”
Retrograde Changes in Presynaptic Function Driven by Dendritic mTORC1
Henry, F. E., McCartney, A. J., Neely, R., Perez, A. S., Carruthers, C. J. L., Stuenkel, E. L., Inoki, K., & Sutton, M. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2149-12.2012 · Cited by 71
“While relatively acute mTORC1 activation ( 24 h) in our experiments did not alter postsynaptic function directly, there is evidence to suggest that longer, chronic hyperactivation of neuronal mTORC1, via knockdown of TSC1 or TSC2, is associated with morphological and functional changes in the postsynaptic compartment…”
BackgroundLinking pathways in the developing and aging brain with neurodegeneration
Kovács, G. G., Adle‐Biassette, H., Milenković, I., Cipriani, S., van Scheppingen, J., & Aronica, E. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.045 · Cited by 74
Liu, S., Zhou, L., Yuan, H., Vieira, M., Sanz-Clemente, A., Badger, J. D., Lu, W., Traynelis, S. F., & Roche, K. W. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0827-16.2017 · Cited by 69
“Interestingly, increased spine density was observed in Purkinje cells of TSC1-null mice (Tsai et al., 2012), whereas reduction of spine density was reported in hippocampal and cortical neurons lacking TSC1 (Tavazoie et al., 2005; Meikle et al., 2008).”
BackgroundCurrent Approaches and Future Directions for the Treatment of mTORopathies
Karalis, V., & Bateup, H. S. (2021) · Developmental Neuroscience · doi:10.1159/000515672 · Cited by 67
Ehninger, D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.015 · Cited by 71
Everolimus alters white matter diffusion in tuberous sclerosis complex
Tillema, J., Leach, J. L., Krueger, D. A., & Franz, D. N. (2012) · Neurology · doi:10.1212/wnl.0b013e318247ca8d · Cited by 71
Synaptic Signaling and Aberrant RNA Splicing in Autism Spectrum Disorders
Smith, R. M., & Sadée, W. (2011) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2011.00001 · Cited by 74
“Loss of any one of these three genes is sufficient to alter neuron morphology (Li et al., 2001; Tavazoie et al., 2005; Hsueh, 2007) and perturb glutamatergic and GABAergic signaling (Husi et al., 2000; Costa et al., 2002; von der Brelie et al., 2006).”
Nuclear and Mitochondrial Genome Defects in Autisms
Smith, M., Spence, M. A., & Flodman, P. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03571.x · Cited by 73
Lin, T. V., Hsieh, L., Kimura, T., Malone, T. J., & Bordey, A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605740113 · Cited by 67
“Our spine data complement studies reporting that some TSC– Rheb effects on spines are dependent on autophagy (38) or are potentially mTORC1-independent (23, 39).”
BackgroundTargeted treatment trials for tuberous sclerosis and autism: no longer a dream
Şahin, M. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.04.008 · Cited by 70
“In Tsc1 deficient hippocampal neurons, the AMPA/NMDA receptor current ratio is increased, suggesting a relative enhancement of synaptic AMPA receptors [27].”
Tordjman, S., Cohen, D., Anderson, G. M., Botbol, M., Canitano, R., Coulon, N., & Roubertoux, P. L. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.01.014 · Cited by 76
Rett Syndrome: Genes, Synapses, Circuits, and Therapeutics
Banerjee, A., Castro, J., & Sur, M. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00034 · Cited by 64
“Rett syndrome, Fragile-X syndrome (FXS), and TSC are examples of monogenic disorders that show compromised synaptic plasticity (Tavazoie et al., 2005; Moretti et al., 2006; Talos et al., 2008).”
The Tuberous Sclerosis Complex
(2007) · New England Journal of Medicine · doi:10.1056/nejmc062928 · Cited by 41
Stafstrom, C. E., Staedtke, V., & Comi, A. M. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00087 · Cited by 73
Li, Y., Cao, J., Chen, M., Li, J., Sun, Y., Zhang, Y., Zhu, Y., Wang, L., & Zhang, C. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.02.020 · Cited by 62
“Loss of a single copy of TSC1 was sufficient to perturb dendritic spine structure (Tavazoie et al., 2005).”
BackgroundInfluentialDrosophila as a Model Organism for the Study of Neuropsychiatric Disorders
O’Kane, C. J. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_110 · Cited by 73
“2010), and Tsc1 and Tsc2 regulate dendritic spine size and synapse function (Tavaziole et al. 2005).”
BackgroundCuratolo, P., Aronica, E., Jansen, A., Jansen, F. E., Kotulska, K., Lagae, L. G., Moavero, R., & Jóźwiak, S. (2015) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2015.12.005 · Cited by 63
Somatic mutation: The hidden genetics of brain malformations and focal epilepsies
Ye, Z., McQuillan, L., Poduri, A., Green, T. E., Matsumoto, N., Mefford, H. C., Scheffer, I. E., Berkovic, S. F., & Hildebrand, M. S. (2019) · Epilepsy Research · doi:10.1016/j.eplepsyres.2019.106161 · Cited by 66
The Neurobiology of the Tuberous Sclerosis Complex
Marcotte, L. M., & Crino, P. B. (2006) · NeuroMolecular Medicine · doi:10.1385/nmm:8:4:531 · Cited by 65
Chévere-Torres, I., Maki, J. M., Santini, E., & Klann, E. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.07.018 · Cited by 65
Current Management of Tuberous Sclerosis Complex
Krueger, D. A., & Franz, D. N. (2008) · Pediatric Drugs · doi:10.2165/00148581-200810050-00004 · Cited by 67
Magdalon, J., Sánchez-Sánchez, S. M., Griesi‐Oliveira, K., & Sertie, A. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030659 · Cited by 60
“Notwithstanding, some conflicting results exist regarding normal/increased neurite length [78,79], reduced/normal/increased dendritic spine density and length [51,75,76,80,85,86] and increased spine head width/immature shape [75,85] (Table 1), possibly due to the use of different animal models or experimental conditio…”
BackgroundInfluentialDendritic spine detection using curvilinear structure detector and LDA classifier
Zhang, Y., Zhou, X., Witt, R. M., Sabatini, B. L., Adjeroh, D., & Wong, S. T. C. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.02.044 · Cited by 60
“The morphological and statistical changes of small cellular compartments, such as the dendritic spines, are of great interest when studying neurons (Tavazoie et al., 2005; Sarbassov et al., 2005; Carter and Sabatini, 2004; Zhou et al., 2006).”
BackgroundSelf-citationRüegg, S. J., Baybis, M., Juul, H., Dichter, M. A., & Crino, P. B. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2007.09.009 · Cited by 59
“[PubMed: 8757244] El-Hashemite N, Zhang H, Henske EP, Kwiatkowski DJ. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma.”
BackgroundInfluentialMolecular Therapies for Tuberous Sclerosis and Neurofibromatosis
Franz, D. N., & Weiss, B. D. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0269-4 · Cited by 58
“Developing neurons acquire an abnormal morphology, with large cell bodies, multiple axons, and few, large, dendritic spines, decreased myelin, and abnormal synaptic architecture [40, 62–68].”
BackgroundDynamic Switch of Negative Feedback Regulation in Drosophila Akt–TOR Signaling
Kockel, L., Kerr, K. S., Melnick, M., Brückner, K., Hebrok, M., & Perrimon, N. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000990 · Cited by 62
“However, the dAktTsc2 link might be less physiologically relevant than initially suggested [75,104,105], pointing to additional regulatory connections of the InR-PI3K-dAkt and Tsc1/Tsc2-Rheb-TORC1 signaling branches [20,99,106,107,108,109].”
BackgroundTuberous Sclerosis: A New Frontier in Targeted Treatment of Autism
Davis, P. E., Peters, J. M., Krueger, D. A., & Şahin, M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0359-5 · Cited by 62
Wilson, C. H., Bonnet, C. S., Guy, C., Idziaszczyk, S., Colley, J., Humphreys, V., Maynard, J., Sampson, J. R., & Cheadle, J. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1740 · Cited by 60
“Furthermore, this neuronal morphology becomes more pronounced after loss of the 2nd Tsc1 allele, suggesting that the TSC pathway is sensitive to gene dosage (30).”
BackgroundHuang, Y., Kang, B. N., Tian, J., Liu, Y., Luo, H. R., Hester, L., & Snyder, S. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4489-06.2007 · Cited by 57
“The mTOR pathway is well established to influence dendritic spine morphology (Jaworski et al., 2005; Kumar et al., 2005; Tavazoie et al., 2005).”
InfluentialMechanisms of TSC-mediated Control of Synapse Assembly and Axon Guidance
Knox, S. M., Ge, H., Dimitroff, B. D., Ren, Y., Howe, K. A., Arsham, A. M., Easterday, M. C., Neufeld, T. P., O’Connor, M. B., & Selleck, S. B. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000375 · Cited by 62
“Loss of TSC function produces changes in dendritic architecture of hippocampal neurons and altered synaptic properties [2].”
BackgroundResultInfluentialBoer, K., Troost, D., Timmermans, W., Gorter, J. A., Spliet, W. G. M., Nellist, M. D., Jansen, F. E., & Aronica, E. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.073 · Cited by 57
Efficacy of Sirolimus in Treating Tuberous Sclerosis and Lymphangioleiomyomatosis
Paul, E., & Thiele, E. A. (2008) · New England Journal of Medicine · doi:10.1056/nejme0707153 · Cited by 56
Robust 3D reconstruction and identification of dendritic spines from optical microscopy imaging
Janoos, F., Mosaliganti, K. R., Xu, X., Machiraju, R., Huang, K., & Wong, S. T. C. (2008) · Medical Image Analysis · doi:10.1016/j.media.2008.06.019 · Cited by 58
“, 1997), tuberous sclerosis complex syndrome (Tavazoie et al., 2005), and other neurological diseases.”
BackgroundŞahin, M., Henske, E. P., Manning, B. D., Ess, K. C., Bissler, J. J., Klann, E., Kwiatkowski, D. J., Roberds, S. L., Silva, A. J., Hillaire‐Clarke, C. S., et al. (2016) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2016.03.015 · Cited by 63
Self-citationCortical hyperexcitability and epileptogenesis: Understanding the mechanisms of epilepsy - Part 2
Badawy, R. A. B., Harvey, A. S., & Macdonell, R. A. L. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2008.10.001 · Cited by 64
Malik, R., Pai, E. L.-L., Rubin, A. N., Stafford, A. M., Angara, K., Minasi, P., Rubenstein, J. L. R., Sohal, V. S., & Vogt, D. L. (2019) · Nature Communications · doi:10.1038/s41467-019-12962-4 · Cited by 58
Wu, J., McCallum, S. E., Glick, S. D., & Huang, Y. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.10.041 · Cited by 53
Henry, F. E., Hockeimer, W., Chen, A., Mysore, S. P., & Sutton, M. A. (2017) · Molecular Brain · doi:10.1186/s13041-017-0330-y · Cited by 53
“Within a population of hippocampal neurons fixed and imaged following 24 h expression of eGFP alone or alongside either RhebQ64L or the upstream mTORC1 inhibitors TSC1/2 as a basis of comparison (Fig.”
BackgroundMethodResultInfluentialVolders, K., Nuytens, K., & Creemers, J. W. M. (2011) · Current Molecular Medicine · doi:10.2174/156652411795243432 · Cited by 60
Amegandjin, C. A., Choudhury, M., Jadhav, V., Carriço, J. N., Quintal, A., Berryer, M. H., Snapyan, M., Chattopadhyaya, B., Saghatelyan, A., & Cristo, G. D. (2021) · Nature Communications · doi:10.1038/s41467-021-23939-7 · Cited by 56
Metadata
- Authors
- Tavazoie, S. F., Alvarez, V. A., Ridenour, D. A., Kwiatkowski, D. J., & Sabatini, B. L.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Sabatini, Bernardo L
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2005-11-06
- Volume
- 8
- Issue
- 12
- Pages
- 1727-1734
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1977617725
- Cited by
- 497
- References
- 51
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 14 · 2023: 17 · 2022: 17 · 2021: 21 · 2020: 29 · 2019: 22 · 2018: 20 · 2017: 26 · 2016: 26 · 2015: 28 · 2014: 25 · 2013: 29 · 2012: 45
- FWCI
- 14.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (5 T32 NS07484, T32NS007484)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- TSC1, TSC2, tuberous sclerosis complex, neuronal morphology, dendritic spines, hippocampal pyramidal neurons, glutamatergic synapses, cofilin, actin cytoskeleton, epilepsy, autism spectrum disorder, intellectual disability
- MeSH terms
- Tuberous Sclerosis Complex 1 Protein, Tuberous Sclerosis Complex 2 Protein, Animals, Brain, Cell Differentiation, Cell Line, Hippocampus, Humans, Mice, Transgenic, Neurons, Phosphorylation, Tuberous Sclerosis, Rats, Sprague-Dawley, Pyramidal Cells, Mice, Knockout, Gene Expression Regulation, Developmental, Tumor Suppressor Proteins, Cell Shape, Dendritic Spines, Cofilin 1, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.